Showing results (141-150 of 223) with videos related to

Sort By:
Pageof 23
American Journal of Hematology|June 14, 2013
Current survival measures reliably reflect modern sequential treatment in CML: correlation with prognostic stratificationsTomas Pavlik, Eva Janousova, Jiri Mayer, et al.
The New England Journal of Medicine|June 8, 2010
Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemiaHagop Kantarjian, Neil P Shah, Andreas Hochhaus, et al.
Annals of Hematology|March 21, 2009
Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent yearsSebastian Giebel, Myriam Labopin, Jerzy Holowiecki, et al.
The New England Journal of Medicine|March 5, 2015
Bortezomib-based therapy for newly diagnosed mantle-cell lymphomaTadeusz Robak, Huiqiang Huang, Jie Jin, et al.
Ejhaem|February 26, 2024
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosisStephen T Oh, Srdan Verstovsek, Vikas Gupta, et al.
Scientific Reports|May 13, 2021
COVID-19's natural course among ambulatory monitored outpatientsBarbora Weinbergerova, Jiri Mayer, Stepan Hrabovsky, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2012
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trialJürgen Finke, Claudia Schmoor, Wolfgang A Bethge, et al.
Leukemia|August 21, 2023
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trialMikkael A Sekeres, Pau Montesinos, Jan Novak, et al.
Cancers|August 27, 2021
The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPNStefan Tillmann, Kathrin Olschok, Sarah K Schröder, et al.
American Journal of Hematology|February 4, 2015
Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II studyMichael Doubek, Yvona Brychtova, Anna Panovska, et al.
Pageof 23